APRIL 22, 2026 • San Francisco

City View at Metreon

WHAT IS
UNLOCK 2026?

UNLOCK 2026 is a one-day only summit on April 22nd in San Francisco, focused on how AI is changing drug discovery and life sciences.

Through keynote talks and expert panels, Unlock creates a forum for substantive discussion about where AI is genuinely advancing biological research and where challenges remain.

Speakers include EVPs and SVPs from major pharma companies, founders and builders from the leading AI-bio companies, and researchers from top labs.

JOIN US TO EXPLORE WHAT’S NEXT AND HELP SHAPE IT.

AI Science: Cutting Through the Hype

•

AI Science: Cutting Through the Hype •


OUR SPEAKERS

AVIV REGEV

Executive Vice President • Genentech

Founder & CEO • Medra

DAVID BAKER

Director, Institute for Protein Design & 2024 Nobel Laureate in Chemistry • University of Washington

Co-Founder & CEO • BigHat Biosciences

Co-Founder & CEO • Noetik

Head of Science Operations • Palantir

Co-Founder & COO • Ginkgo Bioworks

CEO • Cultivarium

Partner • Khosla Ventures

Co-founder & CSO • Gordian Biotechnologies

AI/ML Partnerships • Lilly

VP, Global Head of Partnerships, AI • AbbVie

Co-founder & CEO • Transfyr

Co-Founder & CTO • Goodfire

Life Sciences • Anthropic

SVP & Head of Biomedical AI • Xaira Therapeutics

SVP, AI-Enabled Discovery • Xaira Therapeutics

Co-Founder & Head of Science • Edison Scientific

Partner • Lux Capital

Co-founder & Member of Technical Staff • Coefficient Bio

Co-founder & CEO • Radical AI

Chief AI Officer • AstraZeneca

SVP, Therapeutic Discovery Sciences • Bristol Myers Squibb

Founder & CEO • Axiom Math 

Co-Founder & CEO • Generalist

Founder & General Partner • Atria Ventures

Co-Founder, CFO & COO • Terray Therapeutics

Partner • Menlo Ventures

Core Investigator • Arc Institute

Associate Director of Machine Learning • Arc Institute

Global Head, External Scientific Innovation • Johnson & Johnson

Co-founder & General Partner • Dimension Capital

Co-founder & President • NewLimit

FAQ

  • Unlock is an invite-only, one-day summit on April 22, 2026 in San Francisco, focused on how AI is changing drug discovery and life sciences.

    Through keynote talks and expert panels, Unlock creates a forum for substantive discussion about where AI is genuinely advancing biological research and where challenges remain. 

    Speakers include EVPs and SVPs from major pharma companies, founders and builders from the leading AI-bio companies, and researchers from top labs.

    Join us to explore what’s next and help shape it.


  • April 22, 2026
    City View at Metreon
    135 4th St
    San Francisco, CA

  • Yourself, a colleague, a laptop or tablet for live demos and business cards for networking—the rest is on us.

  • Photography, video, and audio recording may take place throughout the conference for documentation, promotional, and educational use. By attending Unlock 2026, you acknowledge and consent to the possibility of being captured in event media.

    If you prefer not to be photographed or recorded, please notify event organizers in advance or speak with staff on site so reasonable efforts can be made to accommodate your request.

  • Yes. Lunch and Reception. A variety of dietary needs will be covered however, if you have a specific need you are concerned about please reach out to us at Unlock@medra.ai

  • Unfortunately, no animals are allowed at the event, with the exception of licensed service animals.

SPEAKER AFFILIATIONS

Medra Logo

OUR ATTENDEE COMMUNITY